203 related articles for article (PubMed ID: 9170427)
21. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
[TBL] [Abstract][Full Text] [Related]
22. A comparison of Tl-201, Tc-99m sestamibi, and Tc-99m tetrofosmin myocardial perfusion scintigraphy in patients with mild to moderate coronary stenosis.
Reyes E; Loong CY; Harbinson M; Rahman S; Prvulovich E; Ell PJ; Anagnostopoulos C; Underwood SR
J Nucl Cardiol; 2006 Jul; 13(4):488-94. PubMed ID: 16919572
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
24. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
25. Uptake of 99mTc-tetrofosmin, 99mTc-MIBI and 201Tl in malignant thymoma.
Hashimoto T; Goto K; Hishinuma Y; Yachuda K; Sugioka Y; Arai K; Harada S; Goto M
Ann Nucl Med; 2000 Aug; 14(4):293-8. PubMed ID: 11023030
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Tc-99m MIBI and Tl-201 uptake in musculoskeletal lesions.
Adalet I; Ozger H; Cantez S
Clin Nucl Med; 1996 Feb; 21(2):118-21. PubMed ID: 8697680
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
28. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
29. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
[TBL] [Abstract][Full Text] [Related]
30. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.
Caner B; Kitapçl M; Unlü M; Erbengi G; Calikoğlu T; Göğüş T; Bekdik C
J Nucl Med; 1992 Mar; 33(3):319-24. PubMed ID: 1531501
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
32. Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines.
Rodrigues M; Kalinowska W; Zielinski C; Sinzinger H
Nucl Med Commun; 2001 Jun; 22(6):645-50. PubMed ID: 11403175
[TBL] [Abstract][Full Text] [Related]
33. Evaluating benign and malignant musculoskeletal lesions with radionuclide angiography and SPECT using Tc-99m MIBI.
Ishiyama K; Tomura N; Okada K; Nagasawa H; Sashi R; Sasaki K; Sato K; Watarai J
Clin Nucl Med; 2005 Sep; 30(9):598-603. PubMed ID: 16100476
[TBL] [Abstract][Full Text] [Related]
34. Effects of extracellular Na+ and Ca2+ ions and Ca2+ channel modulators on the cell-associated activity of 99mTc-MIBI and 99mTc-tetrofosmin in tumour cells.
Arbab AS; Ueki J; Koizumi K; Araki T
Nucl Med Commun; 2003 Feb; 24(2):155-66. PubMed ID: 12548040
[TBL] [Abstract][Full Text] [Related]
35. [Musculoskeletal tumor evaluation with 99mTc-Tetrofosmin].
García-Reyna JC; Rico Martínez G; Vega González IF; Linares LM; Delgado Cedillo EA; Romero Ramírez R
Acta Ortop Mex; 2008; 22(6):390-6. PubMed ID: 19280840
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study on the tumor accumulation of 99mTc-tetrofosmin and 99mTc-MIBI in rabbits bearing VX-2 cancer].
Otsuka N; Tamada T; Mimura H; Sone T; Morita K; Tomomitsu T; Yanagimoto S; Fukunaga M
Kaku Igaku; 1997 Oct; 34(10):939-43. PubMed ID: 9404102
[TBL] [Abstract][Full Text] [Related]
38. Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA accumulation in recurrent malignant thymoma.
Kim SJ; Kim IJ; Kim YK
Clin Nucl Med; 2002 Jan; 27(1):30-3. PubMed ID: 11805481
[TBL] [Abstract][Full Text] [Related]
39. Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines.
de Jong M; Bernard BF; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; Krenning EP
Eur J Nucl Med; 1996 Oct; 23(10):1361-6. PubMed ID: 8781141
[TBL] [Abstract][Full Text] [Related]
40. 99Tc(m)-tetrofosmin scintimammography for detecting breast cancer: a comparative study with 99Tc(m)-MIBI.
Horne T; Pappo I; Cohen-Pour M; Baumer M; Orda R
Nucl Med Commun; 2001 Jul; 22(7):807-11. PubMed ID: 11453054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]